Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 23Peritoneal Neoplasms 15Fallopian Tube Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Ovarian Epithelial 5Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Brain Neoplasms 2Appendiceal Neoplasms 2Adrenocortical Carcinoma 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Postoperative Complications 1Peritoneal Cavity Cancer 1Peritoneal Cancer 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroblastoma 1

Interventions

Fluorodeoxyglucose F18 1Cytoreduction Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cytoreductive Surgery × Cytoreduction Surgical Procedures × Clear all
NCT05633199 2022-12-01

Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer

Women's Hospital School Of Medicine Zhejiang University

Phase NA Not yet recruiting
140 enrolled

Cytoreductive Surgery

Data powered by HemOnc (CC BY 4.0) Colophon âš¡